Saturday, July 31, 2021
HomeUncategorizedAstrazeneca Pharma India soars 20pc on delisting proposal

Astrazeneca Pharma India soars 20pc on delisting proposal

Shares in Astrazeneca Pharma India surged 20 per cent to their maximum daily limit after the drug maker said its board would meet on Wednesday to discuss delisting proposal.

AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, to initiate a voluntary delisting process.

Astrazeneca Pharmaceuticals AB holds 75 per cent in AstraZeneca Pharma India.

Most Popular

- Advertisment -